Skip to content

Japanese Strabismus Outcomes Assessment and Research Group Study

Establishing Real-World Evidence in Japanese Strabismus Care Through a Multicenter Study: Japanese Strabismus Outcomes Assessment and Research (J-SOAR) Group Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07763457
Acronym
J-SOAR
Enrollment
10000
Registered
2026-08-13
Start date
2026-09-01
Completion date
2032-12-31
Last updated
2026-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismus

Keywords

strabismus surgery, machine learning, nomogram, real-world evidence, natural history

Brief summary

This retrospective study constructs the largest multicenter registry of strabismus care in Japan. The registry evaluates real-world surgical and conservative treatment outcomes, safety, and natural history for various types of strabismus, including common, rare, and complex cases.

Detailed description

This retrospective multicenter cohort study collects clinical data from participating academic and high-volume centers in Japan. To minimize chronological bias and maintain feasibility, the observation period depends on the target disease. For common types of strabismus, data extraction is limited to a recent timeframe (e.g., the past 3 years) to avoid the influence of behavioral changes during the coronavirus disease 2019 (COVID-19) pandemic. For rare and complex strabismus, the extraction period extends up to 10 years (from January 2016 to the date of Institutional Review Board approval) to secure an adequate sample size. Statistical analyses will incorporate mixed-effects models to adjust for institutional clustering and differences in patient backgrounds. Missing data will be addressed via multiple imputation before developing prediction models with machine learning algorithms such as random forests.

Interventions

Surgical correction of ocular deviation.

OTHERConservative Treatment or Observation

Non-surgical management, including clinical observation for natural history, prism therapy, or orthoptic treatment.

Sponsors

Kyoto University, Graduate School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with strabismus who underwent clinical evaluation or management (including observation for natural history, conservative treatment, or surgery) at participating institutions. * Observation period for common strabismus: A restricted recent timeframe (e.g., the most recent 3 years) to minimize selection bias. * Observation period for rare and complex strabismus: Up to 10 years (January 1, 2016, to the date of Institutional Review Board approval) to secure an adequate sample size.

Exclusion criteria

* Patients who formally opted out of data utilization for this study.

Design outcomes

Primary

MeasureTime frameDescription
Success rate of ocular deviation correction and residual deviation angleAt standard observation intervals (2 to 4 weeks, 3 to 6 months, 1 year, and 2 years post-treatment or baseline) and through study completion, up to 10 years.Assess the angle of ocular deviation and determine the success rate of clinical management (including observation for natural history, surgical, or conservative treatments) based on established clinical criteria.

Secondary

MeasureTime frameDescription
Recovery of binocular visual functionThrough study completion, up to 10 yearsEvaluate binocularity using standardized clinical tests.
Predictive accuracy of the machine learning nomogramThrough study completion, up to 10 yearsCompare the predictive performance of the developed machine learning models against actual surgical outcomes.

Countries

Japan

Contacts

CONTACTManabu Miyata, MD, PhD
miyatam@kuhp.kyoto-u.ac.jp+81-75-751-3248

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 14, 2026